Alexander Scheiter

815 total citations
17 papers, 194 citations indexed

About

Alexander Scheiter is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Alexander Scheiter has authored 17 papers receiving a total of 194 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 5 papers in Surgery. Recurrent topics in Alexander Scheiter's work include Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers), MRI in cancer diagnosis (2 papers) and Liver Disease Diagnosis and Treatment (2 papers). Alexander Scheiter is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers), MRI in cancer diagnosis (2 papers) and Liver Disease Diagnosis and Treatment (2 papers). Alexander Scheiter collaborates with scholars based in Germany, United States and Taiwan. Alexander Scheiter's co-authors include Philip R. Williams, Jan Philipp Bewersdorf, Ronald Naumann, Martin Kerschensteiner, Christoph Mahler, Maarten E. Witte, Thomas Misgeld, Paula Sánchez, Oliver Griesbeck and Diego F. Calvisi and has published in prestigious journals such as Neuron, Scientific Reports and The American Journal of Surgical Pathology.

In The Last Decade

Alexander Scheiter

17 papers receiving 192 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alexander Scheiter Germany 7 57 48 39 37 35 17 194
Irene Carretero‐Barrio Spain 8 52 0.9× 22 0.5× 22 0.6× 37 1.0× 64 1.8× 25 211
Adam Sandor United States 9 34 0.6× 14 0.3× 51 1.3× 48 1.3× 27 0.8× 10 260
Katherine Howe United States 5 23 0.4× 21 0.4× 17 0.4× 47 1.3× 17 0.5× 6 193
Nenad Kunac Croatia 10 65 1.1× 24 0.5× 13 0.3× 97 2.6× 24 0.7× 22 212
Marion Benazra France 6 41 0.7× 20 0.4× 56 1.4× 45 1.2× 25 0.7× 8 218
Jeremy Klein United States 7 14 0.2× 22 0.5× 29 0.7× 68 1.8× 10 0.3× 12 236
Benjamin I. Meyer United States 9 43 0.8× 25 0.5× 45 1.2× 125 3.4× 11 0.3× 27 337
Shaoping She China 7 42 0.7× 18 0.4× 32 0.8× 70 1.9× 7 0.2× 12 208
Ryosuke Hiwa Japan 9 39 0.7× 44 0.9× 17 0.4× 32 0.9× 15 0.4× 37 212

Countries citing papers authored by Alexander Scheiter

Since Specialization
Citations

This map shows the geographic impact of Alexander Scheiter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Scheiter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Scheiter more than expected).

Fields of papers citing papers by Alexander Scheiter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander Scheiter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Scheiter. The network helps show where Alexander Scheiter may publish in the future.

Co-authorship network of co-authors of Alexander Scheiter

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander Scheiter. A scholar is included among the top collaborators of Alexander Scheiter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander Scheiter. Alexander Scheiter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Böhm, Dieter, Thomas Ganslandt, Patrick Metzger, et al.. (2025). Empowering personalized oncology: evolution of digital support and visualization tools for molecular tumor boards. BMC Medical Informatics and Decision Making. 25(1). 29–29. 1 indexed citations
2.
Scheiter, Alexander, et al.. (2023). Complex Roles of PTPN11/SHP2 in Carcinogenesis and Prospect of Targeting SHP2 in Cancer Therapy. PubMed. 8(1). 15–33. 1 indexed citations
3.
Klemm, S. A., Katja Evert, Kirsten Utpatel, et al.. (2023). Identification of DUSP4/6 overexpression as a potential rheostat to NRAS-induced hepatocarcinogenesis. BMC Cancer. 23(1). 1086–1086. 2 indexed citations
4.
Kaneko, Kota, Yan Liang, Qing Liu, et al.. (2023). Identification of CD133+ intercellsomes in intercellular communication to offset intracellular signal deficit. eLife. 12. 2 indexed citations
5.
Kaneko, Kota, Yan Liang, Qing Liu, et al.. (2023). Identification of CD133+ intercellsomes in intercellular communication to offset intracellular signal deficit. eLife. 12. 2 indexed citations
6.
Scheiter, Alexander, Felix Keil, Cédric Coulouarn, et al.. (2022). Wnt/β-Catenin-Pathway Alterations and Homologous Recombination Deficiency in Cholangiocarcinoma Cell Lines and Clinical Samples: Towards Specific Vulnerabilities. Journal of Personalized Medicine. 12(8). 1270–1270. 3 indexed citations
7.
Utpatel, Kirsten, Alexander Scheiter, Claudia Fellner, et al.. (2022). Application of A U-Net for Map-like Segmentation and Classification of Discontinuous Fibrosis Distribution in Gd-EOB-DTPA-Enhanced Liver MRI. Diagnostics. 12(8). 1938–1938. 2 indexed citations
8.
Nooijen, Lynn E., Jesús M. Bañales, Marieke T. de Boer, et al.. (2022). Impact of Positive Lymph Nodes and Resection Margin Status on the Overall Survival of Patients with Resected Perihilar Cholangiocarcinoma: The ENSCCA Registry. Cancers. 14(10). 2389–2389. 16 indexed citations
9.
Teufel, Andreas, Nadja M. Meindl‐Beinker, Michael Gerken, et al.. (2022). Characteristics and outcome of patients with small bowel adenocarcinoma (SBA). Journal of Cancer Research and Clinical Oncology. 149(8). 4579–4590. 3 indexed citations
10.
Scheiter, Alexander, Florian Lüke, Felix Keil, et al.. (2021). STRN-ALKFusion in a Case of Malignant Peritoneal Mesothelioma: Mixed Response to Crizotinib, Mode of Resistance, and Brigatinib Sequential Therapy. JCO Precision Oncology. 5(5). 1507–1513. 4 indexed citations
11.
Evert, Katja, Thomas Dienemann, Christoph Brochhausen, et al.. (2021). Autopsy findings after long-term treatment of COVID-19 patients with microbiological correlation. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 479(1). 97–108. 34 indexed citations
12.
Scheiter, Alexander, Katja Evert, Antonio Cigliano, et al.. (2021). RASSF1A independence and early galectin‐1 upregulation in PIK3CA‐induced hepatocarcinogenesis: new therapeutic venues. Molecular Oncology. 16(5). 1091–1118. 12 indexed citations
13.
Haimerl, Michael, Kirsten Utpatel, Florian Zeman, et al.. (2021). Quantification of contrast agent uptake in the hepatobiliary phase helps to differentiate hepatocellular carcinoma grade. Scientific Reports. 11(1). 22991–22991. 8 indexed citations
14.
Scheiter, Alexander, Felix Keil, Florian Lüke, et al.. (2021). Identification and In-Depth Analysis of the Novel FGFR2-NDC80 Fusion in a Cholangiocarcinoma Patient: Implication for Therapy. Current Oncology. 28(2). 1161–1169. 5 indexed citations
15.
Jesinghaus, Moritz, Alexander Scheiter, Björn Konukiewitz, et al.. (2021). Morphology Matters. The American Journal of Surgical Pathology. 45(7). 969–978. 24 indexed citations
16.
Witte, Maarten E., Christoph Mahler, Jan Philipp Bewersdorf, et al.. (2019). Calcium Influx through Plasma-Membrane Nanoruptures Drives Axon Degeneration in a Model of Multiple Sclerosis. Neuron. 101(4). 615–624.e5. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026